EcoDrugPlus

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSPPRG00000001401
Gene Symbol: IKBKB
4 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSPPRG00000004153
Gene Symbol: IMPDH1
3 Cross references
333 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSPPRG00000006003
Gene Symbol: IMPDH2
4 Cross references
200 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPPRG00000011130
Gene Symbol: INPP5D
3 Cross references
213 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSPPRG00000007786
Gene Symbol: IGF1R
4 Cross references
274 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSPPRG00000009528
Gene Symbol: INSR
3 Cross references
288 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSPPRG00000000366
Gene Symbol: ITGA2B
4 Cross references
189 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSPPRG00000022623
Gene Symbol: ITGA4
4 Cross references
236 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSPPRG00000006266
Gene Symbol: ITGA5
3 Cross references
269 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSPPRG00000024855
Gene Symbol: ITGAV
3 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSPPRG00000023118
Gene Symbol: ITGB1
4 Cross references
298 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSPPRG00000005247
Gene Symbol: ITGB5
4 Cross references
210 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).